Recombinant factor VIIa in trauma patients with the 'triad of death'

Biswadev Mitra, Peter Cameron, Michael Parr, Louise Phillips

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


The use of recombinant factor VIIa (rFVIIa) in trauma patients is usually part of rescue therapy when haemorrhage and coagulopathy have not responded to conventional treatment. In this scenario, trauma patients are likely to have one or more components of the a??triad of deatha?? (coagulopathy, acidosis and hypothermia). The aim of this study was to report on the outcome of trauma patients with the a??triad of deatha?? immediately prior to receiving rFVIIa.
Original languageEnglish
Pages (from-to)1409 - 1414
Number of pages6
Issue number9
Publication statusPublished - 2012

Cite this